These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28992673)

  • 1. Reflux Hypersensitivity: A New Functional Esophageal Disorder.
    Yamasaki T; Fass R
    J Neurogastroenterol Motil; 2017 Oct; 23(4):495-503. PubMed ID: 28992673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on Functional Heartburn.
    Yamasaki T; O'Neil J; Fass R
    Gastroenterol Hepatol (N Y); 2017 Dec; 13(12):725-734. PubMed ID: 29339948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective-serotonin reuptake inhibitors for the treatment of hypersensitive esophagus.
    Viazis N; Karamanolis G; Vienna E; Karamanolis DG
    Therap Adv Gastroenterol; 2011 Sep; 4(5):295-300. PubMed ID: 21922028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure.
    de Bortoli N; Martinucci I; Savarino E; Franchi R; Bertani L; Russo S; Ceccarelli L; Costa F; Bellini M; Blandizzi C; Savarino V; Marchi S
    Dis Esophagus; 2016 Jan; 29(1):3-9. PubMed ID: 25212408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipramine for Treatment of Esophageal Hypersensitivity and Functional Heartburn: A Randomized Placebo-Controlled Trial.
    Limsrivilai J; Charatcharoenwitthaya P; Pausawasdi N; Leelakusolvong S
    Am J Gastroenterol; 2016 Feb; 111(2):217-24. PubMed ID: 26753892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to use Rome IV criteria in the evaluation of esophageal disorders.
    Schmulson M
    Curr Opin Gastroenterol; 2018 Jul; 34(4):258-265. PubMed ID: 29846258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders.
    Abdallah J; George N; Yamasaki T; Ganocy S; Fass R
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1073-1080.e1. PubMed ID: 29913281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease.
    Savarino E; Marabotto E; Zentilin P; Frazzoni M; Sammito G; Bonfanti D; Sconfienza L; Assandri L; Gemignani L; Malesci A; Savarino V
    Dig Liver Dis; 2011 Jul; 43(7):542-7. PubMed ID: 21376679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and Management of Functional Chest Pain in the Rome IV Era.
    Fass R; Shibli F; Tawil J
    J Neurogastroenterol Motil; 2019 Oct; 25(4):487-498. PubMed ID: 31587539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esophageal hypermotility: cause or effect?
    Crespin OM; Tatum RP; Yates RB; Sahin M; Coskun K; Martin AV; Wright A; Oelschlager BK; Pellegrini CA
    Dis Esophagus; 2016 Jul; 29(5):497-502. PubMed ID: 25893778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Esophageal motility characteristics of refractory heartburn: a study based on high resolution manometry and 24 hour pH-impedance monitoring].
    Wang K; Duan L; Xia Z; Xu Z; Ge Y
    Zhonghua Yi Xue Za Zhi; 2014 Sep; 94(34):2650-5. PubMed ID: 25511590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.
    Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M
    Digestion; 2015; 91(1):19-25. PubMed ID: 25632912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and management of esophageal chest pain].
    Hong SJ
    Korean J Gastroenterol; 2010 Apr; 55(4):217-24. PubMed ID: 20389174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Underlying Mechanisms and Management of Refractory Gastroesophageal Reflux Disease].
    Lee KJ
    Korean J Gastroenterol; 2015 Aug; 66(2):70-4. PubMed ID: 26289239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity to acid is associated with impaired esophageal mucosal integrity in patients with gastroesophageal reflux disease with and without esophagitis.
    Weijenborg PW; Smout AJ; Verseijden C; van Veen HA; Verheij J; de Jonge WJ; Bredenoord AJ
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G323-9. PubMed ID: 24924748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncardiac chest pain: diagnosis and management.
    Yamasaki T; Fass R
    Curr Opin Gastroenterol; 2017 Jul; 33(4):293-300. PubMed ID: 28463855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives.
    Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Savarino V; Savarino E
    Dig Dis Sci; 2017 Aug; 62(8):1881-1889. PubMed ID: 28550489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: double-blind placebo-controlled trial.
    Ostovaneh MR; Saeidi B; Hajifathalian K; Farrokhi-Khajeh-Pasha Y; Fotouhi A; Mirbagheri SS; Emami H; Barzin G; Mirbagheri SA
    Neurogastroenterol Motil; 2014 May; 26(5):670-8. PubMed ID: 24533896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Esophageal Hypersensitivity in Functional Heartburn.
    Kondo T; Miwa H
    J Clin Gastroenterol; 2017 Aug; 51(7):571-578. PubMed ID: 28682989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.